Bristol-Myers Squibb Company (LON:0R1F)

London flag London · Delayed Price · Currency is GBP · Price in USD
44.30
+0.55 (1.26%)
At close: Aug 1, 2025
1.26%
Market Cap67.97B
Revenue (ttm)34.82B
Net Income (ttm)3.69B
Shares Outn/a
EPS (ttm)1.81
PE Ratio18.44
Forward PE6.89
Dividend1.89 (4.27%)
Ex-Dividend DateJul 3, 2025
Volume16,601
Average Volume7,607
Open43.63
Previous Close43.75
Day's Range43.30 - 44.45
52-Week Range41.99 - 63.17
Beta0.37
RSI32.66
Earnings DateJul 31, 2025

About ATSG

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R1F
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.